Zahangir Khaled, MD
Pediatric Gastroenterology · Springfield, ILNPI 1356316715
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.4%), consulting fees and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Sanofi at 58.5% of the total. Reporting peaked in 2024 at $1,892 and has fallen 87.1% since, to $243 in 2025.
Across 72 payments — averaging $42.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Regeneron Healthcare Solutions, Inc.$456
- AbbVie$323
- Takeda Pharmaceuticals U.S.A., Inc.$181
- Merck$66
- Mirum Pharmaceuticals, Inc.$42
- plus $188 from 8 others
Across 45 payments — averaging $1123.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$27K
- Pfizer$17K
- Janssen Research & Development, LLC$5K
- AbbVie$2K
What the payments were for
- Consulting fees$1,39646%
- Food & beverage$1,61553%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 18 | $1,769 |
| Regeneron Healthcare Solutions, Inc. | 19 | $456 |
| AbbVie | 9 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $181 |
| Merck | 4 | $66 |
| Mirum Pharmaceuticals, Inc. | 2 | $42 |
| Shire North American Group Inc | 2 | $36 |
| Boehringer Ingelheim | 2 | $30 |
| Johnson & Johnson | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Metacel Pharmaceuticals LLC | 1 | $19 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$1,396
How this compares
$3,025 in reported general payments places this provider in the 80th percentile of 58 pediatric gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric gastroenterology in Springfield
- Charmaine Mziray-AndrewSpringfield$2K
- James BermanSpringfield$282
- Joshua WechslerChicago$433K
- Valeria CohranChicago$212K
- Lee BassChicago$149K
- Alyssa KriegermeierChicago$22K
- Thirumazhisai GunasekaranPark Ridge$9K
- Ritu VermaChicago$8K
- Stefano GuandaliniChicago$7K
- Rajeev NagpalOak Lawn$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.